TTOO - T2 Biosystems Inc. (TTOO) Q4 2023 Earnings Call Transcript
2024-02-15 19:37:10 ET
T2 Biosystems, Inc. (TTOO)
Q4 2023 Earnings Conference Call
February 15, 2024, 04:30 PM ET
Company Participants
Trip Taylor - IR
John Sperzel - Chairman & CEO
John Sprague - John Sprague
Conference Call Participants
Ben Haynor - Alliance Global
Presentation
Operator
Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results Conference Call. At this time, all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentation.
It is now pleasure to turn the floor over to your host, Trip Taylor, Investor Relations. Sir, the floor is yours.
Trip Taylor
Thank you, operator. I'd like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems’ future financial and operating results and plans for developing and marketing new products. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements, including the risks and uncertainties described in T2 Biosystems’ annual report on Form 10-K filed with the SEC on March 31, 2023, and other filings the company makes with the SEC from time to time. The company undertakes no obligation to publicly update or revise any forward-looking statements except as required by law.
With that, I would like to turn the call over to Chairman and CEO, John Sperzel. John?...
T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript